Astute Medical, a San Diego-based medical diagnostic company, said March 8 that it completed a $13 million financing round, which was an extension of a $12.5 million round completed in May.
Together with an initial investment round of $6.2 million, Astute has raised $45.7 million since its founding in 2007.
Among the investors in the latest round are the same that participated in last year’s round including Domain Associates, Delphi Ventures, De Novo Ventures and Johnson & Johnson Development Corp.
The company makes diagnostic tools that improve the detection of high-risk conditions through the identification and validation of protein biomarkers.
— Mike Allen